Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07622901 · ClinicalTrials.gov registry record · NA
Fasting InTervention for Endometrial Cancer
A NA study, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT07622901 is a NA study that is actively recruiting participants, run by University of Miami. The registered enrollment target is 42 participants.
The verdict
NCT07622901, a NA study, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The goal of this study is to find out if it is safe for women with endometrial cancer who are going to have surgery to fast (not eat) overnight. Studies have shown that women with endometrial cancer often have problems with metabolism, like high blood sugar. These problems can cause inflammation and may help cancer grow or make treatment less effective. Early research shows that fasting overnight might help improve these problems.
Interventions
- PROCEDURE Blood Specimen Collection
- PROCEDURE Hysterectomy
- BEHAVIORAL Prolonged Overnight Fasting (POF)
- OTHER Blood Sugar Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07622901
The ClinicalTrials.gov registry entry for NCT07622901 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Blood Specimen Collection is the first listed.
NCT07622901 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07622901 about?
NCT07622901 is a clinical study titled "Fasting InTervention for Endometrial Cancer". The goal of this study is to find out if it is safe for women with endometrial cancer who are going to have surgery to fast (not eat) overnight. Studies have shown that women with endometrial cancer often have problems with metabolism, like high blood sugar. These problems can cause inflammation and...
What is the current status of trial NCT07622901?
This trial is currently recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2026-07-01. Estimated completion is 2028-07-01.
What interventions are being tested in trial NCT07622901?
The interventions under investigation include: Blood Specimen Collection (PROCEDURE), Hysterectomy (PROCEDURE), Prolonged Overnight Fasting (POF) (BEHAVIORAL), Blood Sugar Monitor (OTHER).
Who is sponsoring clinical trial NCT07622901?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.